Continental Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q1
Sell
-30,000
Closed -$1.61M 134
2013
Q4
$1.61M Sell
30,000
-20,000
-40% -$1.19M 0.35% 81
2013
Q3
$3.09M Hold
50,000
0.77% 37
2013
Q2
$3.03M Buy
+50,000
New +$2.98M 0.85% 38

Other funds holding DGX

Continental Advisors's DGX Position: Q1 2015 in Review

Continental Advisors sold out of Quest Diagnostics (DGX) in Q1 2015, closing a stake of 15,000 shares — an estimated $1.01M sold.

Continental Advisors first reported a position in DGX in Q2 2013 and held it in 7 quarters. The position peaked at $1.71M in Q1 2014. 553 funds tracked by Wall St. Rank hold DGX as of Q1 2015.

  • Continental Advisors reported no remaining Quest Diagnostics position as of Q1 2015 after selling out during the quarter.
  • Continental Advisors sold 15,000 Quest Diagnostics shares in Q1 2015, an estimated $1.01M.
  • Continental Advisors first reported a position in Quest Diagnostics in Q2 2013 and held it in 7 quarters.
  • Continental Advisors's Quest Diagnostics position peaked at $1.71M in Q1 2014.
  • 553 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2015.

Based on Continental Advisors's 13F filing for Q1 2015, filed 15 May 2015.